Bad Drugs or Big Law Stress? Jury to Decide in Reed Smith Partner's Suicide

, The Am Law Daily

   | 2 Comments

Stewart Dolin, a leader of Reed Smith’s corporate department, committed suicide in 2010. His widow seeks $12 million for his death, alleging it was the result of an antidepressant whose suicidal side effects were covered up by GlaxoSmithKline. The pharmaceutical giant claims that Dolin’s death was the result of an unpleasant work environment.

This content has been archived. It is available exclusively through our partner LexisNexis®.

To view this content, please continue to Lexis Advance®.

Continue to Lexis Advance®

Not a Lexis Advance® Subscriber? Subscribe Now

Why am I seeing this?

LexisNexis® is now the exclusive third party online distributor of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® customers will be able to access and use ALM's content by subscribing to the LexisNexis® services via Lexis Advance®. This includes content from the National Law Journal®, The American Lawyer®, Law Technology News®, The New York Law Journal® and Corporate Counsel®, as well as ALM's other newspapers, directories, legal treatises, published and unpublished court opinions, and other sources of legal information.

ALM's content plays a significant role in your work and research, and now through this alliance LexisNexis® will bring you access to an even more comprehensive collection of legal content.

For questions call 1-877-256-2472 or contact us at customercare@alm.com

What's being said

  • jasfermariquit

    Learning the system of Superior Trading system helped me in standing up again. I’ve been through my darkest hours, a few months ago. But when I learned their methods and strategies it helped me got up again. Search Superior Trading System to know more.

  • Andrew

    Is it really necessary to be detailing the notes from his reviews on here?

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article #1202781576400

Thank you!

This article's comments will be reviewed.